Top Markets
#1 MowCat MowCat +526.85%
#2 龙虾 (Lobster) 龙虾 (Lobster) +87.16%
#3 Magma Finance Magma Finance +40.75%
#4 Akedo Akedo +36.23%
#5 SIXSEVEN SIXSEVEN +30.35%
#6 Cortex Cortex +25.50%
#7 DeXe DeXe +16.75%
#8 OpenEden OpenEden +16.58%
#9 Pons Pons +15.57%
#10 MarsCoin MarsCoin +13.89%
Coin of the day
MowCat MowCat
Ayarlar
Dil
TüRKçE
Para birimi
USD
Tema
Staidson (Beijing) BioPharmaceuticals Co., Ltd. Staidson (Beijing) BioPharmaceuticals Co., Ltd.

Staidson (Beijing) BioPharmaceuticals Co., Ltd.

300204
Hisse Senetlerindeki Sıralama #7952
Staidson (Beijing) BioPharmaceuticals Co., Ltd. is a Chinese biopharmaceutical... Staidson (Beijing) BioPharmaceuticals Co., Ltd. is a Chinese biopharmaceutical company that specializes in the entire lifecycle of therapeutic drugs, from research and development to production and market distribution. Their product portfolio encompasses a variety of drug types, including advanced protein-based medicines like therapeutic monoclonal antibodies, innovative gene and cell therapies, and conventional chemical pharmaceuticals. The company's primary therapeutic areas address conditions related to the nervous system, infectious diseases, gastrointestinal health, the urinary system, and autoimmune disorders. Notably, Staidson has established a strategic partnership with Pivotal S.L. to conduct clinical trials in Europe for BDB-001, a monoclonal anti-C5a antibody, aimed at treating patients with severe, progressive COVID-19 caused by the SARS-CoV-2 virus. Founded in 2002, the company's headquarters are located in Beijing, China.
Hisse Fiyatı
$3.11
Piyasa Değeri
$1.41B
Değişim (1 gün)
-1.97%
Değişim (1 yıl)
-57.22%
Ülke
CN
Ticaret Staidson (Beijing) BioPharmaceuticals Co., Ltd. (300204)

Kategori

Healthcare
Staidson (Beijing) BioPharmaceuticals Co., Ltd. (300204) için kazanç
2026 itibarıyla kazanç TTM: 0
Staidson (Beijing) BioPharmaceuticals Co., Ltd. şirketinin en son finansal raporlarına göre, mevcut kazancı 0'dir. 2026 yılında şirket 0 kazanç elde etti, bu 2026 yılındaki 0 kazanca göre önceki yıla eşit. Bu sayfada gösterilen kazanç, faiz ve vergiler öncesi kazançtır; yani EBIT.
Staidson (Beijing) BioPharmaceuticals Co., Ltd. için kazanç geçmişi 2026 - 2026
Her yılın sonundaki kazanç
Yıl Kazanç Değiştir
Sağlanan tarihler için yeterli veri yok.
Benzer şirketler veya rakipler için kazanç
Şirket Kazanç Kazanç Farkı Ülke
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH